Loading company…
Massachusetts-based discovery-stage company developing new treatments for fibrosis, built on Massachusetts General and Brigham research.
Founded in 2018 and based in Massachusetts, US, Mediar Therapeutics, Inc. is a discovery-stage company developing new treatments for fibrosis. It was founded by Mass General Brigham Ventures, and its technology comes from research at Massachusetts General Hospital and Brigham and Women's Hospital. In December 2025 it raised USD 37.85 million in Series B funding from new investors Amplitude, Asahi Kasei Corporate Venture Capital, Intermediate Capital Group and Longwood Fund.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in